MiNK Therapeutics, Inc.INKTNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank0
3Y CAGR-37.5%
5Y CAGR-9.9%
Year-over-Year Change
Research and development spending
3Y CAGR
-37.5%/yr
Annual compound
5Y CAGR
-9.9%/yr
Recent deceleration
Percentile
P0
Near historical low
vs 5Y Ago
0.6x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $5.65M | -10.8% |
| 2024 | $6.34M | -59.1% |
| 2023 | $15.49M | -33.0% |
| 2022 | $23.12M | +65.5% |
| 2021 | $13.97M | +46.9% |
| 2020 | $9.51M | -51.6% |
| 2019 | $19.65M | - |